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Mouse vs man: Organoid models of brain development & disease
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H I G H L I G H T S
• We show how brain organoids can be used to study development and disease.
• We compare advantages and disadvantages of mouse and human organoids.
• We argue that mice and mouse organoids remain useful for research in this ﬁeld.
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A B S T R A C T
Brain organoids have rapidly become established as promising tools for studying both the normal embryonic
development of the brain and the mechanistic roots of neurodevelopmental disorders. Most recent studies are
based on brain organoids derived from human pluripotent stem cells (PSCs), as these are likely to be the best way
to understand normal human development and disease. However, brain organoids grown from mouse cells still
have a role to play. We discuss recent work showing how mice and mouse organoids can be employed to
complement studies using human organoids. Mouse stem cell-derived organoids are useful for the development
of improved protocols to generate organoids, including brain region-speciﬁc organoids. Importantly, the wealth
of existing in vivo data on mouse brain development together with detailed descriptions of mutant phenotypes
provide invaluable points of comparison to validate organoids as tools to study the genetics of brain develop-
ment. Further, organoids have signiﬁcant potential to replace or reduce the numbers of animals used in studies of
normal brain development.
1. Introduction – modelling brain development
Understanding how the brain normally develops during embry-
ogenesis represents a major challenge. It is important because many
neurodevelopmental disorders most likely arise as a consequence of
early development going wrong in some way, so we can only fully
understand the root causes of such disorders if we ﬁrst understand how
the brain develops normally. Ultimately, understanding how the brain
develops will allow us to devise rational strategies for alleviating neu-
rodevelopmental disorders. It is very diﬃcult to study early human
brain development directly because of the ethical and practical con-
straints on research with human embryos, so scientists have relied on
alternatives instead, such as animal models. In the last few decades, the
mouse has been probably the most commonly used model to understand
brain development, mainly due to the relative ease by which mice can
be genetically manipulated; for example by the addition or inactivation
of speciﬁc genes in their genome. Mouse models have allowed us to
learn a great deal about normal brain development, to identify and
study the function of many of the genes required for this complex
process and has greatly improved our understanding of the develop-
mental origins of neurodevelopmental disorders (Del Pino et al., 2018).
While there are clear similarities between the developing brains of
humans and mice, as we learn more about human development, it has
become increasingly clear that there are also important diﬀerences
between these species; notably, cell cycle times of neural progenitors
are much longer in human than in the mouse, and humans show a
greater complexity of progenitor types (Fig. 1) (reviewed by Florio and
Huttner, 2014; Mason and Price, 2016). Further, diﬀerences in the
overall structure of mouse and human brains can make it diﬃcult to use
mice to model certain neurodevelopmental disorders. For example,
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humans with mutations in the DOUBLECORTEX (DCX) gene have lis-
sencephaly (smooth cerebral cortex) as a consequence of defective
migration of neural cells. However, mutant mice lacking the equivalent
gene have no such defects (Corbo et al., 2002), at least in part because
the mouse cortex is normally smooth, in contrast to the gyrencephalic
human cortex. Given these limitations to the mouse as a model for
understanding human brain development, scientists have continued to
seek alternative models, to complement or even replace studies using
mice. Currently, brain organoids represent the most promising such
alternative model (see Table 1).
2. Brain organoids
Brain organoids are complex three-dimensional structures grown
from pluripotent stem cells (PSCs) that mimic the cell-type composition
and tissue organization of the embryonic brain (Lancaster and
Knoblich, 2014). Organoids can readily be grown from either mouse or
human PSCs and the latter allow ready access to early stages of human
brain development for the ﬁrst time. Interestingly, key diﬀerences be-
tween mouse and human cerebral cortex development are reproduced
in organoids – progenitor cells in human organoids show increased cell
cycle times compared to mouse, and human organoids contain many
more outer radial glia (oRG) progenitors than do mouse organoids, as
found in vivo (Kadoshima et al., 2013; Lancaster et al., 2013). The po-
tential applications and limitations of brain organoids as tools to un-
derstand development and disease have been extensively reviewed re-
cently (including Amin and Pasca, 2018; Brown et al., 2018;
Giandomenico and Lancaster, 2017; Qian et al., 2019). As organoids
have opened up the possibility of studying human embryonic brain
directly, this raises the question of whether there is still a place for
studies using organoids grown from mouse cells. Here, we argue that
cerebral organoids derived from mouse cells still have useful roles to
play.
A large number of studies using cerebral organoids have been
published in the last few years, the overwhelming majority of which
employed human PSCs. The two most likely reasons that human stem
cell-derived brain organoids have largely supplanted studies based on
mouse cells are (i) as outlined above, the best way to study human-
speciﬁc development is to use human cells and tissues and (ii) the
availability of induced pluripotent stem cells (iPSCs) (Takahashi and
Yamanaka, 2006). iPSCS can be derived from any individual, including
those aﬀected by a neurodevelopmental disorder, to form patient-spe-
ciﬁc cell lines. This makes them ideal tools to investigate mechanisms
underlying genetic disorders, as they have exactly the same genetic
makeup as the patient (Lancaster and Knoblich, 2014). Further,
CRISPR/Cas9 gene targeting allows the straightforward correction of
patient-speciﬁc mutations, to demonstrate that speciﬁc phenotypes are
indeed due to speciﬁc mutations. The relative merits of mouse and
human stem cell-based methods speciﬁcally to model schizophrenia
and autism were recently reviewed by St Clair and Johnstone (2018).
In studies where the primary focus is on the details of speciﬁc me-
chanisms underlying a particular neurodevelopmental disorder, brain
organoids derived from human PSCs will usually be more appropriate
Fig. 1. Comparison of key diﬀerences in mouse and human cortical develop-
ment. Radial glial cells (RGCs) proliferate and create subpopulations of pro-
genitors including IPCs and oRGs, before diﬀerentiating into neurons which
migrate to the cortical plate. In humans there is a greater abundance of oRGs
which begin to populate a distinct layer, the OSVZ, which is not present in mice.
Organoids have been reported to show these interspecies diﬀerences (Lancaster
et al., 2013). VZ, ventricular zone; SVZ, subventricular zone; ISVZ, inner sub-
ventricular zone; OSVZ, outer subventricular zone; IZ, intermediate zone; CP,
cortical plate; RGC, radial glia cell; IPC, intermediate progenitor cell; oRG,
outer radial glial cell.
Table 1
A summary of some key advantages and disadvantages of organoids derived from mouse or human stem cells.
Mouse Human
Advantages • Fast growth rate, short time scale• Don’t require expensive reagents• Well suited to protocol optimisation• Highly accessible – can directly visualise cells in developing tissues• Wealth of in vivo data, including from mutant lines, to compare
organoids to
• Contain human speciﬁc cell types and layers – best for modelling human
development
• good for modelling human neurodevelopmental disorders• Accessible – can directly visualise cells in developing tissues• Large and rapidly growing literature – many studies, well described, multiple
protocols available
Disadvantages • Often show variability• Lack of vascularization, causes cell death & limits growth• lack human speciﬁc features• less suitable than human organoids for studying neurodevelopmental
disorders
• fewer published studies - less well characterised & fewer protocols
described
• Often show variability• Lack of vascularization – causes cell death & limits growth• Slow growth rate - long time scales• Many reagents are expensive• Little in vivo data to compare human organoids too. Often compared to mouse
studies.
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than mouse brain organoids. Similarly, in studies aimed at under-
standing aspects of normal brain development that are unique to human
(i.e. not found in mouse), such as folding of the cerebral cortex, mouse
organoids are not likely to be appropriate as they do not exhibit human-
speciﬁc aspects of development. This was illustrated neatly in a study
exploring the function of the PTEN gene, which encodes an important
component of growth factor signalling pathways. Inactivating PTEN in
human-PSC derived brain organoids caused an increase in proliferation
of neural progenitors, leading to an expansion in organoid size and
induced folding in the organoids. In contrast, when PTEN was deleted
in mouse brain organoids no folding of the organoid tissue occurred (Li
et al., 2017).
Our focus here is speciﬁcally on brain organoids, but it should be
noted that organoids corresponding to a great variety of other tissues
can also be grown (reviewed by Rossi et al., 2018). Mouse as well as
human PSCs continue to be widely used in organoid-based studies on at
least some of these other tissues. In part, this could reﬂect the fact that
the brain is more complex than most other tissues, and that many tis-
sues are relatively similar in mouse and human - the diﬀerences be-
tween mouse and human brain are much greater than those between
mouse and human intestine, so mouse intestinal organoids may rea-
sonably be expected to model human intestine more closely than would
be the case for brain. For example, a recent study exploring the me-
chanism by which symmetry is broken during the formation of in-
testinal organoids employed mouse ES cells (Serra et al., 2019). Simi-
larly, in an elegant series of experiments from the Martinez Arias lab,
mouse ES cells were used to generate gastruloids – organoid-type
structures which accurately reproduce key aspects of gastrulating
mouse embryos (Beccari et al., 2018; Turner et al., 2017; van den Brink
et al., 2014).
3. Applications for mouse cell-derived brain organoids
We envisage at least four areas where mouse cell-derived brain or-
ganoids are likely to continue to be useful to scientists for the fore-
seeable future.
3.1. Making better brain organoids
As described above, brain organoids have very rapidly become es-
tablished as popular models to explore mechanisms of brain develop-
ment and understand neurodevelopmental disorders. Nonetheless, the
technology is at an early stage, and current protocols used to grow brain
organoids are not optimal. In particular, there are limitations on the
size to which organoids grow, many organoids contain heterogenous
mixtures of diﬀerentiated cell types and the overall eﬃciency and
consistency of diﬀerentiation can vary considerably between batches of
organoids (Qian et al., 2019). Therefore, there is a continuing need for
new and improved protocols that will consistently produce high quality
organoids that closely resemble embryonic brain. Early protocols for
growing brain organoids were mainly pioneered in the lab of the late
Yoshiki Sasai, initially using mouse embryonic stem (ES) cells (Eiraku
et al., 2008; Nasu et al., 2012; Watanabe et al., 2005). Protocols for
growing brain organoids from human stem cells soon followed
(Kadoshima et al., 2013; Lancaster et al., 2013; Paşca et al., 2015; Qian
et al., 2016; Quadrato et al., 2017). The strategy of ﬁrst optimising
protocols using mouse stem cells, then adapting the protocols to work
with human cells can be very eﬀective. It is attractive because orga-
noids retain their species-speciﬁc developmental timescales, so mouse
brain organoids can be grown in a much shorter time period than
human ones. Typical timescales to produce mouse brain organoids are
around 10–14 days, whereas human brain organoids can take months to
grow (Eiraku et al., 2008; Lancaster et al., 2013; Nasu et al., 2012;
Paşca et al., 2015). Further, many of the reagents required to culture
and maintain human iPSCs are expensive compared to those required
for mouse ES cells. Optimising protocols can be challenging – often a
number of factors, such as signalling molecules, need to be added, each
of which must be present at the correct concentration, at only the
correct time and for the correct duration. Optimising such a large
number of variables using human cells is both time-consuming and
expensive, so it can be both time and cost-eﬃcient to derive protocols
using mouse ES cells in the ﬁrst instance. It is, of course, likely that the
precise timings and duration of exposure to signalling molecules and
other factors required for organoid development will vary between
mouse and human (O'Leary et al., 2007; Paridaen and Huttner, 2014;
Rash and Grove, 2006; Tan and Shi, 2013; Taverna et al., 2014),
however a robust protocol developed in mouse is likely to be a good
starting point for devising a human protocol. Overall, we consider that
developing improved diﬀerentiation protocols is likely to be one of the
major areas in which mouse organoids continue to be of value.
This approach has also been successfully applied to growing orga-
noids corresponding to other complex tissues, such as the kidney.
Taguchi and Nishinakamura (2017) developed a sophisticated protocol
for the production of kidney organoids, by recapitulating key steps of
normal embryonic kidney development. They ﬁrst developed the pro-
tocol using mouse ES cells, then successfully adapted it for use with
human iPSCs.
3.2. Protocols to generate region-speciﬁc brain organoids
Most existing protocols for growing brain organoids from human PS
cells fall into one of two main types. In the ﬁrst type, exempliﬁed by the
protocol developed by Lancaster et al. (2013) cells are not guided to-
wards any one particular brain region, so organoids commonly contain
cells that resemble those found in multiple diﬀerent parts of the brain.
As organoids lack the antero-posterior and dorso-ventral axes found in
the embryonic brain in vivo, these regions do not become organised
within organoids into the normal anatomical arrangement found in the
embryo (Lancaster et al., 2013). Many brain functions require the for-
mation of speciﬁc connections between regions of the developing brain,
but these connections cannot form normally in the organoids, because
the various subregions of the brain are not arranged in the correct
spatial patterns. The second type of protocol for diﬀerentiating orga-
noids attempts to circumvent this issue by using speciﬁc combinations
of factors to generate organoids that correspond to just one brain re-
gion, such as cortex, ventral telencephalon or thalamus (Birey et al.,
2017; Qian et al., 2016; Shiraishi et al., 2017). These region-speciﬁc
organoids can then be combined in culture, to form assemblies of two
diﬀerent regions, which subsequently interact with each other in the
same way as the cognate brain regions do. For example, GABA-ergic
interneurons formed in ventral telencephalic organoids migrate into co-
cultured cortical organoids and produce functional synapses (Birey
et al., 2017). Similarly, reciprocal connections can be formed between
thalamus and cortical organoids, analogous to those found in the em-
bryonic brain (Xiang et al., 2019).
Mouse stem cell-derived organoids are of continuing value in de-
veloping such brain region-speciﬁc organoids, in the same way as de-
scribed above. Indeed, the protocol employed by Xiang et al. (2019) to
grow thalamus-like organoids from human iPSCs was closely based on
one originally designed using mouse ES cells (Shiraishi et al., 2017).
3.3. Developing and optimising new technologies
Just as mouse ES cell-derived brain organoids are of value in opti-
mising protocols to make better organoids, they can be used as tools to
optimise other types of experimental protocols. For example, they were
used to help validate a reﬁned version of CRISPR/Cas9 technology
which employs two gRNAs in combination to greatly increase the ef-
ﬁciency of biallelic inactivation of several genes implicated in brain
development in mouse ES cells (Acosta et al., 2018).
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3.4. Studying normal mouse brain development
It is also important to note that brain organoids oﬀer signiﬁcant
potential to reduce the number of animals used in studies of brain de-
velopment by replacing the use of mice. One of the key attractions to
using organoids rather than intact embryos to study brain development
is their accessibility – this allows investigators to visualise and track the
behaviours of individual cells within organoids in a way that would not
be possible in intact embryos, especially at the earliest stages when
embryos are particularly inaccessible. Examples of this include the
tracking of interkinetic nuclear migration of GFP-marked radial in
mouse ES cell-derived organoids (Nasu et al., 2012) and quantitation of
the rate of neurogenesis in brain organoids grown from primary cortical
progenitor cells isolated from mouse embryos expressing a Tbr2-GFP
reporter transgene (Kosodo et al., 2017). Mouse brain organoids are
therefore useful as tools to study basic cell biological processes that are
required for normal brain development.
Analysis of chimaeric mouse embryos is a powerful tool for ex-
ploring gene functions and mechanisms (West, 1999). Making chi-
maeric organoids is a straightforward case of mixing mutant and con-
trol ES cells together in appropriate ratios, then letting organoids
develop. This method was used recently with mouse ES cell-derived
organoids to show that cell-surface heparan sulphate proteoglycans
(HSPGs) are essential for setting up gradients of the signalling molecule
sonic hedgehog (Shh) which has multiple roles in the development of
the nervous system (Guo and Roelink, 2019).
Mouse brain organoids have also been employed to great eﬀect in a
study of the mechanisms by which antero-posterior pattern is initially
set up in the early neuroectoderm (Takata et al., 2017). This is im-
portant, because understanding how the early regionalisation of the
nervous system is achieved in vivo will help guide future attempts to
make high-quality organoids corresponding to speciﬁc brain regions.
3.5. Comparing phenotypes in mutant organoids and embryos.
One particular advantage of mouse organoids that should not be
overlooked is the wealth of existing published in vivo data on mouse
brain development, including detailed descriptions of the phenotypic
consequences of mutations in genes that regulate brain development.
This means that we can compare the eﬀects of mutating such genes in
organoids with the well described phenotypes found in mutant mice,
giving us conﬁdence that the regulatory mechanisms acting within
brain organoids are indeed the same as those acting in embryos, and
therefore that organoids are truly valid models of brain development.
This will be increasingly important in studies exploring gene functions
in human PSC-derived organoids, where the high degree of variability
between organoids can make it diﬃcult to be conﬁdent whether an
apparent phenotype is truly caused by a mutation, or whether it is a
result of inter-experiment variability.
As yet, there are few examples in the literature of studies comparing
the eﬀects of the same mutation in mouse organoids to those in the
equivalent mutant mouse. One such study used mouse organoids to
investigate the transcription factor Foxg1 (Mall et al., 2017). Foxg1 is a
high-level regulator of multiple aspects of forebrain development.
Homozygous mutant mice completely lack ventral telencephalon, have
dramatically smaller cerebral cortices and die at birth (Martynoga et al.,
2005; Xuan et al., 1995). Mutations in human FOXG1 cause FOXG1
syndrome, a severe neurodevelopmental disorder (Vegas et al., 2018).
Brain organoids grown from mouse ES cells in which both copies of
Foxg1 had been inactivated showed reduced diﬀerentiation of cortical
progenitor cells, which is consistent with part of the mouse phenotype
(Mall et al., 2017), however as ﬁndings were based mainly on qRT-PCR
data and no immunohistochemically stained sections were included, it’s
diﬃcult to be certain from this study exactly how closely the organoid
phenotype matches the mouse one.
4. Some limitations of organoids can be overcome using mice
Although organoids closely resemble normal tissue, it is important
to remember that there are key diﬀerences. One of the major limitations
of current cerebral organoids (both human and mouse) is that they lack
vasculature and blood circulation. This imposes severe constraints on
the maximum size that organoids can grow to, and the extent to which
they can develop normally (Qian et al., 2019). Mice have been used in
attempts to circumvent this limitation. Successful xenografting of
human brain organoid tissue into mouse brain in vivo has been reported
by several groups. In this scenario, transplanted organoid tissue be-
comes vascularised, allowing it to survive and mature for longer than is
possible in vitro (Daviaud et al., 2018; Mansour et al., 2018). It has also
been suggested that this approach could create a more realistic model
for drug discovery research as it includes a blood brain barrier (Waldau,
2019).
Cerebral organoids have been used to explore the mechanisms by
which infection with Zika virus can lead to microcephaly. Several stu-
dies showed that Zika virus can infect neural progenitor cells in human
cerebral organoids, causing them to cease proliferating and therefore
potentially accounting for the microcephaly seen in babies born to Zika-
infected mothers (Dang et al., 2016; Gabriel et al., 2017; Qian et al.,
2016; Qian et al., 2017; Shao et al., 2016; Yoon et al., 2017). These
papers clearly demonstrate the potential of human organoids to in-
vestigate disease states, however, the situation in vivo is more complex.
The virus must ﬁrst cross the placenta, then the blood brain barrier,
neither of which is present in organoids. Therefore, it is important to
complement the organoid experiments with in vivo studies, using mice,
which more closely resemble the normal situation of Zika infection
(Dowall et al., 2016; Lazear et al., 2016; Li et al., 2016; Tripathi et al.,
2017). This highlights that in vivo models such as mice remain an im-
portant tool to complement some types of human organoid studies.
Finally, an important future avenue for organoid research will in-
volve assembling circuits that resemble those found in the normal
human brain and nervous system. As we cannot yet produce organoids
that perfectly recreate all parts of the brain, an intermediate step in this
work would be to assemble circuits between organoids and explanted
tissue – mouse embryos are the obvious source for obtaining such
tissue, given the practical and ethical constraints on the use of human
embryonic tissue. This principle was recently demonstrated in an ex-
citing study in which human cortical organoids were coupled together
with explants mouse spinal cord and muscle. The organoids formed
functional innervation with the explanted tissue, such that electrical
stimulation of the organoid caused muscle contractions (Giandomenico
et al., 2019).
5. Conclusion
Brain organoids present an exceptionally promising new tool to help
understand brain development and disease. While much research in this
area has employed human cells, we believe that organoids grown from
mouse stem cells still have important roles to play, in particular to help
improve protocols and make better organoids. Mouse and human brain
organoids should be thought of as complementary, rather than com-
peting tools. Similarly, mouse models are likely to remain important as
tools to complement organoid-based studies for many years to come.
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